Pfizer, Genmab Get Speedy FDA Review of Tivdak Full Approval

By Colin Kellaher


Pfizer and Genmab on Tuesday said the U.S. Food and Drug Administration granted priority review to their request to convert the accelerated approval of Tivdak for certain...

Related Keywords

Copenhagen , Køavn , Denmark , Colin Kellaher , Pfizer , Drug Administration , New York Based Pfizer , Dow Jones , Markets ,